Update: Proposed Delisting from the Official List of ASX – Formal Consent of ASX to Delist – Filing of Final Definitive Proxy Statement and Notice of Special Meeting

BOSTON and SYDNEY — 27 May 2020 — GI Dynamics® Inc. (ASX:GID) (“GID” or the “Company”), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, confirms that further to its announcement of 11 May 2020, the Company has...

Appointment of Director

BOSTON and SYDNEY — 2 March 2020 — GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce that it has increased the size of the Board from four to five directors and...